Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention

Yue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang · 2026

Read Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention by Yue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13303037.txt.

Description

A sugar-burning enzyme in immune cells helps drive newborn brain injury, Yue Li and colleagues identify in a 2026 study of hypoxic-ischemic brain damage. Gene-network mining of public datasets singled out hexokinase 2 among glycolysis genes, and a mouse model confirmed the enzyme surging within a day of injury, mostly inside microglia. Blocking it early with the inhibitor 3-bromopyruvate tested causality.

Treated mice showed smaller infarcts, better neurological scores, less lactate buildup, and quieter inflammatory signals. A single early dose still protected brain tissue and behavior thirty days later. The authors nominate the hexokinase-glycolysis axis as an early-intervention target where cooling therapy often falls short.

Catalog record

CREATORYue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48756
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13303037

Browse the full library · About the Tower of Babel